Trial Profile
To evaluate eligibility for initiation of sacubitril/valsartan in heart failure patients : a retrospective, cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2018
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 16 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association